EcoDrugPlus

Ribosomal Protein L30

Ensembl ID : ENSMMMG00000015872
Gene Symbol: RPL30
2 Cross references
273 Possible Orthologues:

Ribosomal Protein L31

Ensembl ID : ENSMMMG00000019483
Gene Symbol: RPL31
2 Cross references
154 Possible Orthologues:

Ribosomal Protein L34

Ensembl ID : ENSMMMG00000010314
Gene Symbol: RPL34
3 Cross references
172 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSMMMG00000018074
Gene Symbol: RPL35
3 Cross references
266 Possible Orthologues:

Ribosomal Protein L36a

Ensembl ID : ENSMMMG00000015764
Gene Symbol: RPL36A
3 Cross references
88 Possible Orthologues:

Ribosomal Protein L37

Ensembl ID : ENSMMMG00000017779
Gene Symbol: RPL37
3 Cross references
314 Possible Orthologues:

Ribosomal Protein L37a

Ensembl ID : ENSMMMG00000017968
Gene Symbol: RPL37A
3 Cross references
99 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSMMMG00000010341
Gene Symbol: RPL38
2 Cross references
201 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSMMMG00000006109
Gene Symbol: RPL4
3 Cross references
308 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSMMMG00000021495
Gene Symbol: RPL6
3 Cross references
389 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSMMMG00000005128
Gene Symbol: RPL7
3 Cross references
195 Possible Orthologues:

Ribosomal Protein L8

Ensembl ID : ENSMMMG00000008492
Gene Symbol: RPL8
3 Cross references
229 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).